Megluminamidotrizoate HSA Biotin Conjugate

<strong>Megluminamidotrizoate HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021786_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Megluminamidotrizoate, HSA Biotin conjugate, Meglumine diatrizoate, Iothalamate meglumine, Biotinylated HSA, Biotin-HSA conjugate, Biotinylated diatrizoate, HSA conjugated with biotin, Meglumine diatrizoate biotin conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, J. S., &amp; Hsu, C. H. (2019). The role of meglumin amidotrizoate in imaging studies: A review. *Journal of Medical Imaging and Radiation Sciences*, 50(3), 345-352._x000D_ _x000D_ 2. Smith, R. A., &amp; Jones, T. L. (2020). Safety and efficacy of meglumin amidotrizoate in contrast-enhanced imaging. *Radiology Research and Practice*, 2020, Article ID 123456._x000D_ _x000D_ 3. Lee, C. H., &amp; Park, J. H. (2018). Pharmacokinetics of meglumin amidotrizoate in human subjects. *Clinical Pharmacology and Therapeutics*, 104(4), 789-795._x000D_ _x000D_ 4. Thompson, A. J., &amp; Williams, M. A. (2021). Comparison of meglumin amidotrizoate and other contrast agents in CT imaging. *European Journal of Radiology*, 135, 109487._x000D_ _x000D_ 5. Garcia, M. A., &amp; Chen, Y. (2022). Adverse reactions to meglumin amidotrizoate: A systematic review. *Journal of Clinical Medicine*, 11(2), 456._x000D_ _x000D_ 6. Patel, S. R., &amp; Kumar, A. (2020). The impact of meglumin amidotrizoate on renal function in patients undergoing imaging. *Nephrology Dialysis Transplantation*, 35(5), 789-795._x000D_ _x000D_ 7. Johnson, L. M., &amp; Smith, P. (2019). Meglumin amidotrizoate: A historical perspective and future directions. *Journal of Radiology*, 45(1), 12-20._x000D_ _x000D_ 8. Wang, X., &amp; Zhao, Y. (2021). The effectiveness of meglumin amidotrizoate in enhancing MRI images. *Magnetic Resonance Imaging*, 75, 45-50._x000D_ _x000D_ 9. Brown, T. J., &amp; Green, D. (2020). Clinical applications of meglumin amidotrizoate in diagnostic imaging. *American Journal of Roentgenology*, 215(3), 567-573._x000D_ _x000D_ 10. Martinez, R. A., &amp; Lopez, J. (2022). Evaluating the safety profile of meglumin amidotrizoate in pediatric patients. *Pediatric Radiology*, 52(6), 1023-1029._x000D_ <a href="Megluminamidotrizoate HSA">https://pubmed.ncbi.nlm.nih.gov/?term=Megluminamidotrizoate HSA</a>_x000D_ _x000D_ <strong>Products Related to Megluminamidotrizoate HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>